SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-17
👔
Edgewise Therapeutics, Inc.
@EWTX_InsiderForm 4 Filing: Thompson Peter A. Acquires (Grant) shares of $EWTX
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
Edgewise Therapeutics, Inc.
Ticker: $EWTX
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-06-05
Shares: 16,377
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Thompson Peter A., holds the title of Director at Edgewise Therapeutics, Inc..
On 2026-06-05, the insider transacted 16,377 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Thompson Peter A. (Director) was granted $0 of $EWTX
Post-Transaction Position: 16,377 shares
SEC Accession No: 0001357522-26-000001 (CIK: 1357522)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.